𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The additive value of tirofiban administered with a high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: The ADVANCE Trial

✍ Scribed by M. Valgimigli; G. Percoco; D. Barbieriet

Book ID
113414456
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
42 KB
Volume
13
Category
Article
ISSN
1062-1458

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomized two-by-two comparison of hi
A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: The tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial
✍ David J. Moliterno;; the TENACITY Steering Committee; Investigators πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 1 views
Short-Term, High-Dose Atorvastatin Pretr
Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty–Contrast-Induced Nephropathy] Trial
✍ Giuseppe Patti; Elisabetta Ricottini; Annunziata Nusca; Giuseppe Colonna; Vincen πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 811 KB